NCT06663007: RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 72 planned
- Started
- 24 Sep 2024
- Primary completion
- 31 May 2027
- Arms
- Cohort A
- Results
- None posted
- 24 Sep 2024: Trial started
- 29 Oct 2024: Trial registered